Case Report: Everolimus reduced bone turnover markers but showed no clinical benefit in a patient with severe progressive osseous heteroplasia
- Cebey-López, M.
- Currás-Tuala, M.J.
- Gómez-Rial, J.
- Rivero-Calle, I.
- Pardo-Seco, J.
- Mendez-Gallart, R.
- Pischedda, S.
- Gómez-Carballa, A.
- Barral-Arca, R.
- Justicia-Grande, A.
- Viz-Lasheras, S.
- Rodríguez-Tenreiro, C.
- Gómez, R.
- Salas, A.
- Martinón-Torres, F.
Revista:
Frontiers in Pediatrics
ISSN: 2296-2360
Ano de publicación: 2022
Volume: 10
Tipo: Artigo
